Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT

Títulos similares

• Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT
  por: Marie Robin, et al.
  Publicado: (2023-04-01)
• State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019
  por: Donal P. McLornan, et al.
  Publicado: (2019-04-01)
• Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
  por: Joanna Drozd-Sokolowska, et al.
  Publicado: (2024-01-01)
• Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT
  por: Joanna Drozd-Sokolowska, et al.
  Publicado: (2026-04-01)
• Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
  por: Ibrahim Yakoub-Agha, et al.
  Publicado: (2020-02-01)